MariMed targets New York launch in H1 2027 after record $44.2M quarter
FROM THE WIRE · SEEKINGALPHA.COM
Earnings Call Insights: MariMed (MRMD) Q3 2026 MANAGEMENT VIEW * CEO Jon Levine said, "We generated the highest quarterly revenue in our history with growth in both wholesale and retail sequentially and year-over-year," adding that "Adjusted EBITDA rose again sequentially and…
Read at the source ↗MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: expected bullishRecord quarterly revenue and a capital-light expansion may support the stock.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01MariMed reports its highest quarterly revenue in company history.
- 02The CEO cites a total addressable market of over $4 billion in New York.
- 03The company expects to launch in the first half of 2027 and says it is on schedule.
NEWS IMPACT AND MARKET REACTIONChange from the reference price
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets